Juniper Pharma (JNP) Tops Q4 EPS by 43c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St futures slide as rising oil, yields dampen mood
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
Tweet
Share
E-mailGet Alerts JNP Hot Sheet
Join SI Premium – FREE
Juniper Pharma (NASDAQ: JNP) reported Q4 EPS of $0.88, $0.43 better than the analyst estimate of $0.45. Revenue for the quarter came in at $20.9 million versus the consensus estimate of $15.33 million.
For earnings history and earnings-related data on Juniper Pharma (JNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- PepsiCo (PEP) Tops Q3 EPS by 4c, cuts EPS forecast
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
